Biomarkers in psychiatric disorders.
| Autor: | de Jesus JR; Department of Chemistry, Federal University of Viçosa, Viçosa, Minas Gerais, Brazil. Electronic address: jemmyson.jesus@ufv.br., de Araujo Andrade T; Department of Pharmacy, Federal University of Sergipe, São Cristovão, Sergipe, Brazil., de Figueiredo EC; Faculty of Pharmaceutical Sciences, Federal University of Alfenas, Rua Gabriel Monteiro da Silva, Alfenas, Minas Gerais, Brazil. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Advances in clinical chemistry [Adv Clin Chem] 2023; Vol. 116, pp. 183-208. Date of Electronic Publication: 2023 Sep 26. |
| DOI: | 10.1016/bs.acc.2023.05.005 |
| Abstrakt: | Psychiatric disorders represent a significant socioeconomic and healthcare burden worldwide. Of these, schizophrenia, bipolar disorder, major depressive disorder and anxiety are among the most prevalent. Unfortunately, diagnosis remains problematic and largely complicated by the lack of disease specific biomarkers. Accordingly, much research has focused on elucidating these conditions to more fully understand underlying pathophysiology and potentially identify biomarkers, especially those of early stage disease. In this chapter, we review current status of this endeavor as well as the potential development of novel biomarkers for clinical applications and future research study. (Copyright © 2023. Published by Elsevier Inc.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|